Interleukin-10 autoantibodies and HLA-DRB1*01:03 in inflammatory bowel disease (Registro nro. 22776)

000 -Cabecera
Campo de control interno 02873nam a2200301 4500
001 - Número de control
control field ESSALUD
005 - Fecha y hora de la última transacción
Campo de control 20260805113858.0
007 - Tipo material - Descripcion fisica - info general
Tipo material - Descripcion fisica - info general ta
008 - Elementos de Longitud Fija - Información General
Elementos de Longitud Fija - Información t pe ||||| |||| 00| 0 spa d
040 ## - Origen de la Catalogación
Origen de la Catalogación BMG
041 ## - Idioma
Idioma eng
100 ## - Autor
Autor Gharahdaghi, Nima
Rol del Autor Autor
9 (RLIN) 53934
245 ## - Titulo
Titulo Interleukin-10 autoantibodies and HLA-DRB1*01:03 in inflammatory bowel disease
300 ## - Páginas
Paginación páginas: 2212-2222
520 ## - Resumen
Resumen Background: Neutralizing autoantibodies against interleukin-10 can result in a phenocopy of monogenic defects of interleukin-10 signaling in children and may be associated with inflammatory bowel disease (IBD). The allele HLA-DRB1*01:03 is the strongest genetic risk factor for ulcerative colitis.<br/>Methods: We used a cellular interleukin-10 reporter assay and a confirmatory competitive enzyme-linked immunosorbent assay to assess neutralizing interleukin-10 autoantibodies in serum samples obtained from patients with IBD in the Oxford and U.K. IBD BioResource cohorts and from persons without IBD (controls). An in vitro cytokine-release bioassay was performed in a subgroup of patients to assess interleukin-10, interleukin-23, interleukin-1β, tumor necrosis factor, and interleukin-6. We performed HLA association analysis using imputation and high-resolution sequencing.<br/>Results: Interleukin-10–neutralizing autoantibodies were detected in 173 of 4909 patients with IBD (3.5%; 95% confidence interval [CI], 3.0 to 4.1) and in none of 1006 controls (P<0.001). High anti–interleukin-10 activity in serum was associated with a reduction in detectable interleukin-10 and with an exaggerated proinflammatory cytokine response, consistent with functional neutralization of interleukin-10 signaling. Anti–interleukin-10 seropositivity was strongly associated with HLA-DRB1*01:03 on the basis of imputed data from the Oxford cohort (odds ratio, 50.0; 95% CI, 16.4 to 152.3; P=6.14×10−12) and the U.K. IBD BioResource cohort (odds ratio, 24.7; 95% CI, 14.5 to 42.1; P=6.20×10−32) and in a high-resolution sequencing analysis of data from the Oxford cohort (odds ratio, 29.5; 95% CI, 12.2 to 71.1; P=4.85×10−14).<br/>Conclusions: Neutralizing interleukin-10 autoantibodies were present in a subgroup of patients with IBD and were strongly associated with HLA-DRB1*01:03.<br/>
650 ## - Temas - Descriptores
Temas - Descriptores ALERGIA
9 (RLIN) 7055
650 ## - Temas - Descriptores
Temas - Descriptores ENFERMEDAD AUTOINMUNE
9 (RLIN) 53665
650 ## - Temas - Descriptores
Temas - Descriptores GENETICA
9 (RLIN) 1105
650 ## - Temas - Descriptores
Temas - Descriptores GASTROENTEROLOGÍA
9 (RLIN) 12562
650 ## - Temas - Descriptores
Temas - Descriptores ENFERMEDAD INFLAMATORIA INTESTINAL
9 (RLIN) 53935
700 ## - Autor Personal
Autor Personal Yeh, Pai-Jui
9 (RLIN) 53936
700 ## - Autor Personal
Autor Personal Cerón-Gutiérrez, Lourdes
9 (RLIN) 53937
700 ## - Autor Personal
Autor Personal Griffin, Helen
9 (RLIN) 53938
700 ## - Autor Personal
Autor Personal Gordon, Hannah
9 (RLIN) 53939
700 ## - Autor Personal
Autor Personal Jayamanne, Chamara
9 (RLIN) 53940
773 0# - Revista (Relacion con el numero)
Host Biblionumber 22717
Host Itemnumber 22641
Ciudad, Editorial Massachusetts NEJM Group
Codigo barras item/ejemplar NEJM008
Titulo de la Revista The New England Journal of Medicine
Número de control de registro ESSALUD
ISSN 0028-4793
942 ## - Elementos de Koha
Tipo de Documento Artículos
Fecha procesamiento 2026-08-03
Catalogador SQB

No hay ítems disponibles.